Candriam S.C.A. - Q2 2021 holdings

$14.6 Billion is the total value of Candriam S.C.A.'s 1099 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 0.0% .

 Value Shares↓ Weighting
 PRICELINE GRP INCnote 0.900% 9/1$19,148,000
-3.0%
17,5220.0%0.13%
-20.1%
 FORTIVE CORPnote 0.875% 2/1$11,567,000
+1.5%
11,5000.0%0.08%
-16.8%
 WEIBO CORPnote 1.250%11/1$3,903,000
+4.1%
4,0000.0%0.03%
-12.9%
XP  XP INCcl a$2,178,000
+14.3%
50,0000.0%0.02%
-6.2%
TLYS  TILLYS INCcl a$1,918,000
+104.9%
120,0000.0%0.01%
+62.5%
WTRG  ESSENTIAL UTILS INC$1,632,000
+0.6%
35,7120.0%0.01%
-21.4%
 PINDUODUO INCnote 12/0$1,450,000
-12.9%
1,4000.0%0.01%
-28.6%
DLTR  DOLLAR TREE INC$1,252,000
-4.1%
12,5780.0%0.01%
-18.2%
AJG  GALLAGHER ARTHUR J & CO$1,251,000
+17.9%
8,9310.0%0.01%0.0%
INVH  INVITATION HOMES INC$961,000
+30.6%
25,7840.0%0.01%
+16.7%
SUI  SUN CMNTYS INC$995,000
+17.3%
5,8080.0%0.01%0.0%
 BIOMARIN PHARMACEUTICAL INCnote 0.599% 8/0$835,000
+0.6%
8000.0%0.01%
-14.3%
AVLR  AVALARA INC$730,000
+2.7%
4,5100.0%0.01%
-16.7%
LMND  LEMONADE INC$602,000
-6.5%
5,5000.0%0.00%
-20.0%
FANG  DIAMONDBACK ENERGY INC$634,000
+101.9%
6,7520.0%0.00%
+33.3%
RDHL  REDHILL BIOPHARMA LTDsponsored ads$568,000
-10.8%
82,5230.0%0.00%
-20.0%
ASUR  ASURE SOFTWARE INC$231,000
+31.2%
26,0000.0%0.00%
+100.0%
UDR  UDR INC$318,000
+32.5%
6,4990.0%0.00%0.0%
VV  VANGUARD INDEX FDSlarge cap etf$237,000
+19.7%
1,1800.0%0.00%0.0%
IHI  ISHARES TRu.s. med dvc etf$249,000
+15.3%
6900.0%0.00%0.0%
GT  GOODYEAR TIRE & RUBR CO$223,000
+64.0%
13,0310.0%0.00%
+100.0%
FMX  FOMENTO ECONOMICO MEXICANO Sspon adr units$294,000
+15.7%
3,4840.0%0.00%0.0%
PBR  PETROLEO BRASILEIRO SA PETROsponsored adr$308,000
+14.1%
25,1500.0%0.00%0.0%
FBIO  FORTRESS BIOTECH INC$80,000
+17.6%
22,5000.0%0.00%0.0%
CHMA  CHIASMA INC$111,000
+13.3%
23,5000.0%0.00%0.0%
PBCT  PEOPLES UNITED FINANCIAL INC$208,000
+37.7%
12,1630.0%0.00%0.0%
WBK  WESTPAC BANKING CORPsponsored adr$2,0000.0%970.0%0.00%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-07-20
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
MICROSOFT CORP36Q3 20235.9%
GILEAD SCIENCES INC36Q3 20233.1%
MERCK & CO INC NEW36Q3 20232.6%
REGENERON PHARMACEUTICALS36Q3 20232.0%
JOHNSON & JOHNSON36Q3 20232.5%
BIOGEN INC36Q3 20232.6%
PROCTER & GAMBLE CO36Q3 20231.9%
VERTEX PHARMACEUTICALS INC36Q3 20232.1%
META PLATFORMS INC36Q3 20231.6%
VISA INC36Q3 20231.2%

View Candriam S.C.A.'s complete holdings history.

Latest filings
TypeFiled
13F-HR2024-05-06
13F-HR2024-02-14
13F-HR2023-11-13
13F-HR2023-08-08
13F-HR2023-05-12
13F-HR2023-02-13
13F-HR2022-11-10
13F-HR2022-08-03
13F-HR2022-05-13
13F-HR2022-02-10

View Candriam S.C.A.'s complete filings history.

Compare quarters

Export Candriam S.C.A.'s holdings